Chemocentryx Inc (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 8,975 | 15,022 | 9,546 | 56,301 | 9,029 |
| Gross Profit | 8,975 | 15,022 | 9,546 | 56,301 | 9,029 |
| Operating Expenses | 20,508 | 22,507 | 19,402 | 17,009 | 15,939 |
| Operating Income | -11,533 | -7,485 | -9,856 | 39,292 | -6,910 |
| Interest Expense | 423 | 181 | 174 | 0 | 0 |
| Other Income | 1,066 | 792 | 613 | 363 | 350 |
| Pre-tax Income | -10,890 | -6,874 | -9,417 | 39,655 | -6,560 |
| Net Income Continuous | -10,890 | -6,874 | -9,417 | 39,655 | -6,560 |
| Net Income | $-10,890 | $-6,874 | $-9,417 | $39,655 | $-6,560 |
| EPS Basic Total Ops | -0.22 | -0.14 | -0.19 | 0.81 | -0.13 |
| EPS Basic Continuous Ops | -0.22 | -0.14 | -0.19 | 0.82 | -0.14 |
| EPS Diluted Total Ops | -0.22 | -0.14 | -0.19 | 0.80 | -0.13 |
| EPS Diluted Continuous Ops | -0.22 | -0.14 | -0.19 | 0.81 | -0.14 |
| EBITDA(a) | $-11,389 | $-7,369 | $-9,745 | $39,399 | $-6,802 |